Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Obesity Agent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00650806
What this trial is testing

The Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 376
Testing effectiveness (Phase 2)Study completedNCT05121441
What this trial is testing

Study to Evaluate ARD-101 in Adults With Obesity

Who this might be right for
Obesity
Aardvark Therapeutics, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02597101
What this trial is testing

Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInsulin Resistance
Nick Giannoukakis, PhD 14
Testing effectiveness (Phase 2)Study completedNCT00402077
What this trial is testing

Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Who this might be right for
OverweightObesity
AstraZeneca 258
Testing effectiveness (Phase 2)Study completedNCT05215847
What this trial is testing

Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery

Who this might be right for
Bariatric SurgeryObesityWeight Gain
Aardvark Therapeutics, Inc. 12
Not applicableStudy completedNCT05346575
What this trial is testing

Teaching Obesity Treatment Options to Adult Learners (TOTAL): A Multisite RCT

Who this might be right for
ObesityOverweight
VA Office of Research and Development 440
Testing effectiveness (Phase 2)Study completedNCT04095104
What this trial is testing

Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds

Who this might be right for
Obesity, MorbidBariatric SurgeryAdolescent+2 more
University of Colorado, Denver 13
Not applicableLooking for participantsNCT07364175
What this trial is testing

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Who this might be right for
HypertensionObesity & Overweight
Cambridge University Hospitals NHS Foundation Trust 60
Testing effectiveness (Phase 2)Study completedNCT01765608
What this trial is testing

Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients

Who this might be right for
Sleep ApneaObstructive Sleep ApneaObesity
Göteborg University 50
Large-scale testing (Phase 3)Ended earlyNCT00478595
What this trial is testing

Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug

Who this might be right for
ObesityDiabetes Mellitus Type 2
Sanofi 458
Post-approval studies (Phase 4)Study completedNCT03779048
What this trial is testing

Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment

Who this might be right for
Obesity
University of Pennsylvania 147
Not applicableLooking for participantsNCT07387796
What this trial is testing

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Who this might be right for
Drug DiscontinuationSubstance Use DisordersEating Behavior Changes+1 more
The University of Texas at Dallas 40
Large-scale testing (Phase 3)Study completedNCT00532779
What this trial is testing

The Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Who this might be right for
ObesityOverweight
Orexigen Therapeutics, Inc 1,742
Early research (Phase 1)Looking for participantsNCT06575738
What this trial is testing

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Who this might be right for
ObesityAdolescent ObesityBody-Weight Trajectory+3 more
University of Colorado, Denver 40
Not applicableStudy completedNCT00275834
What this trial is testing

Zonisamide for Weight Reduction in Obese Adults

Who this might be right for
Obesity
Duke University 225
Very early researchStudy completedNCT01739192
What this trial is testing

A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence

Who this might be right for
Cocaine Use Disorders
Craig Rush 34
Early research (Phase 1)Study completedNCT01979380
What this trial is testing

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Who this might be right for
Drug Toxicity
Kwang Dong Pharmaceutical co., ltd. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06073184
What this trial is testing

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Who this might be right for
Endometrial CancerAtypical Hyperplasia
University Health Network, Toronto 71
Not applicableUnknownNCT05069298
What this trial is testing

Effect of Silibinin(A) as a Potential Anti-obesity Agent

Who this might be right for
Overweight and ObesityHypercholesterolemiaHypertriglyceridemia
Universidad Católica San Antonio de Murcia 60